Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear.

[1]  H. Meltzer.  Commentary on "Clinical studies on the mechanism of action of clozapine; the dopamine–serotonin hypothesis of schizophrenia." Psychopharmacology (1989) 99:S18–S27 , 2002, Psychopharmacology.

[2]  Takeshi Inoue,et al.  Effect of subchronic lithium treatment on citalopram‐induced increases in extracellular concentrations of serotonin in the medial prefrontal cortex , 2001, Journal of neurochemistry.

[3]  Takeshi Inoue,et al.  Effect of the Dopamine D1/5 Antagonist SCH 23390 on the Acquisition of Conditioned Fear , 2000, Pharmacology Biochemistry and Behavior.

[4]  Takeshi Inoue,et al.  Effects of typical and atypical antipsychotic drugs on freezing behavior induced by conditioned fear , 1996, Pharmacology Biochemistry and Behavior.

[5]  Philip Seeman,et al.  Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine , 1996, Neuropsychopharmacology.

[6]  G. Sedvall,et al.  Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients , 1995, Psychopharmacology.

[7]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[8]  I. Kusumi,et al.  Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. , 1993, The Journal of pharmacology and experimental therapeutics.

[9]  P. Seeman.  Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[10]  D. Middlemiss,et al.  Centrally active 5-HT receptor agonists and antagonists , 1992, Neuroscience & Biobehavioral Reviews.

[11]  C. Saller,et al.  5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade. , 1990, The Journal of pharmacology and experimental therapeutics.

[12]  H. Meltzer,et al.  Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. , 1989, The Journal of pharmacology and experimental therapeutics.

[13]  G. Nowak,et al.  EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors. , 1988, European journal of pharmacology.

[14]  C. Altar,et al.  Dopamine neurochemical profile of atypical antipsychotics resembles that of D-1 antagonists , 1988, Naunyn-Schmiedeberg's Archives of Pharmacology.

[15]  Sakutaro Tadokoro,et al.  Correlation between antiavoidance activities of antipsychotic drugs in rats and daily clinical doses , 1981, Pharmacology Biochemistry and Behavior.

[16]  M. Fanselow,et al.  Conditional and unconditional components of post-shock freezing , 1980, The Pavlovian journal of biological science.

[17]  J. Leysen,et al.  Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors , 2005, Psychopharmacology.

[18]  H. Meltzer,et al.  Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia , 2004, Psychopharmacology.

[19]  M. Bernardi,et al.  Effects of single and long-term haloperidol administration on open field behavior of rats , 2004, Psychopharmacology.

[20]  Julie Kreyenbuhl,et al.  Practice guideline for the treatment of patients with schizophrenia , 1997 .

[21]  O. Olesen,et al.  Long-term lithium administration to rats. Lithium and sodium dosage and administration, avoidance of intoxication, polyuric control rats. , 1974, International pharmacopsychiatry.